ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
16,741 announcements with these filters
Alpex Solar Ltd reported revenue from operations of ₹672 Cr (+105.3% YoY) and net profit of ₹53.3 Cr (+51.0% YoY) for Q4 FY26.
Alpex Solar reported annual total income of ₹2225.73 Crore for FY2026. The board also approved expansion plans for solar glass and wafer manufacturing units.
Urja Global Ltd reported revenue from operations of ₹17.6 Cr (+2.3% YoY) and net profit of ₹0.2 Cr (+100.0% YoY) for Q4 FY26.
Urja Global Limited reported audited financial results for the year ended March 31, 2026. The company also announced key management appointments and resignations effective May-June 2026.
Lux Industries Ltd reported revenue from operations of ₹873 Cr (+6.8% YoY) and net profit of ₹47.3 Cr (-1.5% YoY) for Q4 FY26.
Lux Industries reported audited FY2026 results and recommended a Rs. 2 per share dividend. The Board also approved a proposed scheme to demerge business verticals.
Ambani Orgochem Ltd reported revenue from operations of ₹131.6 Cr (+18.8% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for H2 FY26.
Ambani Orgochem Limited reported its audited financial results for the year ended March 31, 2026. The board approved results showing significantly improved year-on-year revenue performance.
Creative Graphics Solutions reported consolidated annual income of ₹348.93 Crore. The results highlight significant scale following its transition to a public entity.
Arex Industries Ltd reported revenue from operations of ₹12.4 Cr (-1.6% YoY) and net profit of ₹0 Cr for Q4 FY26.
Arex Industries Ltd reported audited annual results and recommended a Rs. 2.50 per share final dividend. Net profit for FY26 stood at ₹1.48 Crore.
Electrotherm (India) Ltd reported revenue from operations of ₹1,140 Cr (-1.8% YoY) and net profit of ₹13.6 Cr (-92.7% YoY) for Q4 FY26.
Medico Remedies Ltd reported revenue from operations of ₹56.8 Cr (+37.5% YoY) and net profit of ₹5.9 Cr (+37.2% YoY) for Q4 FY26.
Electrotherm (India) Limited reported its audited financial results for fiscal year 2026. The results highlight the company's annual performance and consolidated group operations for investors.
Medico Remedies reported a total annual income of ₹212.31 Crore for FY2026. The company achieved a net profit of ₹13.11 Crore during this period.
Prime Cable Industries Ltd reported revenue from operations of ₹144.2 Cr (+69.8% YoY) and net profit of ₹6.8 Cr (+38.8% YoY) for H2 FY26.
Prime Cable Industries reported a net profit of ₹12.24 Crore for the financial year ended March 31, 2026. The Board approved these results during its meeting today.
LE Travenues Technology Ltd reported revenue from operations of ₹308 Cr (+8.4% YoY) and net profit of ₹32 Cr (+90.5% YoY) for Q4 FY26.
Le Travenues Technology reported its FY26 financial results and allotted 4,85,584 equity shares under ESOP schemes. The results show consistent operational performance across business segments.
Life Insurance Corporation of India reported revenue from operations of ₹165,067 Cr (+11.6% YoY) and net profit of ₹23,467 Cr (+23.3% YoY) for Q4 FY26.
LIC approved its FY2026 audited financial results and recommended a Rs. 10 per share final dividend. A 1:1 bonus issue was also confirmed with a record date.
UFO Moviez India Ltd reported revenue from operations of ₹133.2 Cr (+43.2% YoY) and net profit of ₹4.5 Cr for Q4 FY26.
UFO Moviez India Ltd reported consolidated total income of ₹486.38 Crore for FY26. The board approved audited results, reflecting strong annual operational performance for the group.
East Buildtech Ltd reported net profit of ₹1 Cr for Q4 FY26.
East Buildtech Ltd approved its audited financial results for the year ended March 31, 2026. The company reported a standalone net loss of ₹0.49 Crore.
OCCL Ltd reported revenue from operations of ₹149 Cr (+38.6% YoY) and net profit of ₹19.3 Cr (+121.8% YoY) for Q4 FY26.
OCCL Ltd reported annual revenue of ₹505.90 Crore and approved a ₹1.80 per share final dividend. These results reflect steady growth and strong shareholder returns.
Genpharmasec Ltd reported revenue from operations of ₹55.4 Cr (+295.7% YoY) and net profit of ₹1.4 Cr for Q4 FY26.
Genpharmasec Limited reported its audited standalone and consolidated financial results for fiscal year 2026. The board also re-appointed M/s. Abhishek M Agrawal & Co. as internal auditors.
Centrum Capital Ltd reported revenue from operations of ₹1,030 Cr (-7.7% YoY) and a net loss of ₹31.3 Cr for Q4 FY26.